Sfoglia per AUTORE
CECERE F
Collezione AOU San Luigi di Orbassano

  

Items : 11

Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis Of Solid Dominant Stage I Lung Adenocarcinoma. in Clinical lung cancer / Clin Lung Cancer. 2025 Jan 9:S1525-7304(25)00002-6. doi: 10.1016/j.cllc.2025.01.001.
2025
AOU San Luigi di Orbassano

Tajè R; Ambrogi V; Tacconi F; Gallina FT; Alessandrini G; Forcella D; Buglioni S; Visca P; Patirelis A; Cecere FL; Melis E; Vidiri A; Sperduti I; Cappuzzo F; Novello S; Caterino M; Facciolo F;

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11.
2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Salerno F; Camerini A; Carta A; Follador A; Berardi R; Toschi L; Zoratto F; Cortinovis DL; Citarella F; Bulotta A; Rastelli F; Adamo V; Guida A; Manzo A; Cecere FL; Belluomini L; Roca E; Pasello G; Cerea G; Montrone M; Delcuratolo MD; Passiglia F; Guaitoli G; Bertolini F; Genova C; Caliman E; Mazzoni F; Siringo M; Gelibter A; et alii...

Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP). in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Dec;174:118-124. doi: 10.1016/j.lungcan.2022.11.005. Epub 2022 Nov 9.
2022
AOU San Luigi di Orbassano

Passaro A; Russo GL; Passiglia F; D'Arcangelo M; Sbrana A; Russano M; Bonanno L; Giusti R; Metro G; Bertolini F; Grisanti S; Carta A; Cecere F; Montrone M; Massa G; Perrone F; Simionato F; Guaitoli G; Scotti V; Genova C; Lugini A; Bonomi L; Attili I; de Marinis F;

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Baldessari C; Novello S; Bartoli G; Pizzutilo EG; Landi L; Dall'Olio FG; Toschi L; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Bearz A; Camerini A; Sala E; Migliorino MR; Cerea G; Ardizzoni A; Bennati C; Vita E; Del Conte A; Rossi S; Scotti V; Pilotto S; Cecere FL; Proto C; Berardi R; Mazzoni F; et alii...

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Mar;22(3):294-301. doi: 10.1007/s12094-019-02222-8. Epub 2019 Oct 19.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Novello S; Di Maio M; Tiseo M; Galetta D; Bria E; Rossi G; Tabbò F; Cortinovis D; Rizzo P; Delmonte A; Bareggi C; Del Conte A; Sergi C; Casartelli C; Gregorc V; Graziano P; Rossi A; Maiello E; Scotti V; Martelli O; Borra G; Riccardi F; Osman G; Cappuzzo F; Cecere F; Pilotto S; Ghilardi L; Bordi P; Gobbini E; et alii...

Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Feb;140:71-79. doi: 10.1016/j.lungcan.2019.12.006. Epub 2019 Dec 16.
2020
AOU San Luigi di Orbassano
AOU Novara

Novello S; Rossi A; Ferrari S; Zullo A; Vattemi E; Pagano M; Carta A; Martelli O; Gelibter A; Pino MS; Cecere F; Berardi R; Tonini G; Migliorino MR; Sergi C; Galetta D; Scotti V; Nonnis D; Verderame F; Borra G; Piovano PL; Del Conte A; Romano GD; Finocchiaro G; Ceresoli GL; Cortinovis D; Vitiello F; Barbieri F; Tiseo M; et alii...

Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Jul 20;12:1758835920915983. doi: 10.1177/1758835920915983. eCollection 2020
2020
AOU San Luigi di Orbassano

Gelsomino F; Lamberti G; Tiseo M; Rocco D; Pasello G; Cecere FL; Chella A; Grilli G; Mandruzzato M; Tognetto M; Garassino MC; Macerelli M; Novello S; Roila F; Colantonio I; Grossi F; Fiorentino M; Ardizzoni A;

Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional Report. in In vivo (Athens, Greece) / In Vivo. 2019 Nov-Dec;33(6):2021-2026. doi: 10.21873/invivo.11699.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

DI Maio M; Zichi C; Parra HS; Giajlevra M; Gelibter A; Cecere F; Barbieri F; Del Conte A; Chiari R; Catino A; Righi L; Ghisoni E; Mariniello A; Valabrega G; Novello S;

Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2018 Jun;26(6):1841-1849. doi: 10.1007/s00520-017-4004-1. Epub 2017 Dec 21.
2018
AOU San Luigi di Orbassano

Carnio S; Galetta D; Scotti V; Cortinovis DL; Antonuzzo A; Pisconti S; Rossi A; Martelli O; Cecere FL; Lunghi A; Del Conte A; Montagna ES; Topulli J; Pelizzoni D; Rapetti SG; Gianetta M; Pacchiana MV; Pegoraro V; Cataldo N; Bria E; Novello S; Carnio S; Galetta D; Scotti V; Cortinovis DL; Antonuzzo A; Pisconti S; Rossi A; Martelli O; et alii...

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. in Future oncology (London, England) / Future Oncol. 2018 Feb;14(4):353-361. doi: 10.2217/fon-2017-0441. Epub 2017 Nov 14.
2018
AOU San Luigi di Orbassano

Metro G; Passaro A; Lo Russo G; Bonanno L; Giusti R; Gregorc V; Capelletto E; Martelli O; Cecere FL; Giannarelli D; Luciani A; Bearz A; Tuzi A; Scotti V; Tonini G; Galetta D; Carta A; Soto Parra H; Rebonato A; Morabito A; Chiari R; Metro G; Passaro A; Lo Russo G; Bonanno L; Giusti R; Gregorc V; Capelletto E; Martelli O; et alii...

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2016 May;95:73-81. doi: 10.1016/j.lungcan.2016.02.011. Epub 2016 Feb 26.
2016
AOU San Luigi di Orbassano

Vavalà T; Follador A; Tiseo M; Galetta D; Morabito A; Di Maio M; Martelli O; Caffo O; Piovano PL; Cortinovis D; Zilembo N; Casartelli C; Banna GL; Ardizzoia A; Barzelloni ML; Bearz A; Genestreti G; Mucciarini C; Filipazzi V; Menis J; Rizzo E; Barbieri F; Rijavec E; Cecere F; Bria E; Spitaleri G; Rossi A; Novello S;